This content is machine translated Pharmacotherapy for people over 80 A case of age discrimination? SGLT2 inhibitors and GLP1 receptor agonists have emerged as the drugs of first choice in the guidelines for type 2 diabetes. Sulfonylureas and insulin, on the other hand, were deprioritized…
View Post 5 min This content is machine translated Venous leg ulcer Evaluation of innovative therapy methods Ulcus cruris venosum is the most severe form of chronic venous insufficiency. Despite gold standard therapy using compression and phase-adapted hydroactive wound treatment, it is not uncommon for patients with…
View Post 12 min This content is machine translated Palliative care symptom and needs assessment. What screening tools are helpful? In view of the new and mostly well-tolerated therapies, the palliative life and treatment time of oncological patients is increasingly extended. It is a major challenge to identify patients in… CME-Test
View Post 4 min This content is machine translated Parkinson's Individualized therapy concepts for a better quality of life Parkinson’s is the second most common neurodegenerative disease. In Switzerland, around 15,000 people are affected – and the trend is rising. Movement disorders such as tremor, rigor or bradykinesia are…
View Post 8 min This content is machine translated Percutaneous coronary intervention (PCI) Benefits of complete revascularization in elderly patients The benefit of complete revascularization in older patients (≥75 years) with myocardial infarction and multivessel disease is still unclear. At the ESC Congress, however, the results of the FIRE study…
View Post 11 min This content is machine translated Osteoporosis New in diagnostics and therapy Since 2018, the update of the S3 guideline Prophylaxis, Diagnosis and Therapy of Osteoporosis (AWMF 183-001) took place after previous update of the underlying PICO questions (Population-Intervention-Comparison-Outcome questions) for systematic… CME-Test
View Post 13 min This content is machine translated Gerontopsychiatry Focus on polypharmacy – challenges and solutions With age, diseases increase – and so does the likelihood of polypharmacy. However, this presents many challenges, as the heterogeneity and vulnerability of older people requires a differentiated approach. Patients… CME-Test
View Post 12 min This content is machine translated The ageing lung Cellular ageing and senescence What are the causes that lead to an inadequate response to insults? How does an organ like the lung change with age, making the older population more susceptible to age-related… CME-Test
View Post 11 min This content is machine translated Osteoporosis New in diagnostics and therapy Since 2018, the update of the S3 guideline Prophylaxis, Diagnosis and Therapy of Osteoporosis (AWMF 183-001) took place after previous update of the underlying PICO questions (Population-Intervention-Comparison-Outcome questions) for systematic… CME-Test
View Post 12 min This content is machine translated Palliative care symptom and needs assessment. What screening tools are helpful? In view of the new and mostly well-tolerated therapies, the palliative life and treatment time of oncological patients is increasingly extended. It is a major challenge to identify patients in… CME-Test
View Post 3 min This content is machine translated Vertigo Ginkgo biloba contributes to central vestibular compensation In central vestibular vertigo, errors occur in processing information to maintain balance and stabilize gaze due to lesions in the brainstem or cerebellum. The treatment includes, among others, physiotherapeutic and…
